Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. (GHSI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ghsi · stock forecast · 2 analysts (3M) · FMP · updated Nov 10, 2025
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.01
Consensus
$0.01
-99.6% upside
Low
$0.01
Median: $0.012 · Last Close: $3.25
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.24 | ↓ 0.18% |
1-day model range: $3.24–$3.25. Peak: $3.25 (-0.18%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · GHSI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-02-02 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-07-18 | Ascendiant Capital | Maintains | Buy→Buy |
| 2022-03-08 | Maxim Group | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Guardion Health Sciences, Inc. (GHSI) stock. Of the recent 3 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover GHSI.
Analyst Recommendation Trends
GHSI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$7M
↓ 40.3% YoY
Revenue Next Year
$11M
↑ 53.1% YoY
EPS This Year
$-61.00
EPS Next Year
$-7.50
↓ 87.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast GHSI EPS of $-61.00 for the current fiscal year, based on estimates from 1 analysts. The GHSI revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GHSI stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GHSI price target is $0.01 (-99.6% upside), with an analyst consensus of Buy.
The GHSI short-term stock prediction for tomorrow is $3.24 (-0.18%).
Guardion Health Sciences, Inc. trades on OTC under the ticker GHSI. The GHSI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
GHSI forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month GHSI price target is $0.01, with a high forecast of $0.01 and a low of $0.01. The median price target is shown in the chart above when available. This implies -99.6% potential upside from the current price of $3.25.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.